Reporter’s Notebook: Sens. want light shed on costs of Rx drugs | The Daily Star

Health care cost transparency is an idea with growing traction. This week, a bipartisan group of 20 senators expressed support for a proposal from the Centers for Medicare and Medicaid Services that would help increase the transparency and accuracy of prescription drug costs in Medicare Part D.

The senators signed a letter encouraging CMS to adopt the proposal for 2019, which would require that all pharmacy price concessions be reflected in the negotiated price at the point of sale.

The letter notes that part D plan sponsors often claw back price concessions from pharmacies retroactively, sometimes as much as six months after Medicare beneficiaries fill their prescriptions. The proposal would effectively prohibit that practice.

“We have heard from numerous pharmacies in our communities—many of which are rural or medically underserved—that these claw back fees cause so much uncertainty that they do not know if they can continue to serve American families,” said the letter to CMS Administrator Seema Verma.

Read complete article here:

Reporter’s Notebook: Sens. want light shed on costs of Rx drugs | Local News | thedailystar.com.